Nifty
Sensex
:
:
25330.25
82693.71
91.15 (0.36%)
313.02 (0.38%)

Medical Equipment/Supplies/Accessories

Rating :
64/99

BSE: 531768 | NSE: POLYMED

1996.60
17-Sep-2025
  • Open
  • High
  • Low
  • Previous Close
  •  1994.9
  •  2016.2
  •  1985
  •  1989.40
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  260677
  •  518834576.9
  •  3357.8
  •  1821.2

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 20,226.13
  • 56.56
  • 5
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 20,252.44
  • 0.18%
  • 7.08

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 62.44%
  • 2.24%
  • 11.37%
  • FII
  • DII
  • Others
  • 11.41%
  • 10.04%
  • 2.50%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 15.01
  • 16.25
  • 14.40

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 17.89
  • 16.02
  • 11.23

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.71
  • 20.03
  • 23.60

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 54.36
  • 61.53
  • 63.48

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.17
  • 9.18
  • 9.43

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 29.94
  • 37.94
  • 41.36

Earnings Forecasts:

(Updated: 16-09-2025)
Description
2024
2025
2026
2027
Adj EPS
34.13
37.03
45.83
55.46
P/E Ratio
58.50
53.92
43.57
36.00
Revenue
1655.02
1927.27
2307.84
2683.98
EBITDA
453.39
517.99
641.6
751.1
Net Income
338.56
372.89
461.39
555.2
ROA
13.41
10.7
12.3
12.82
P/B Ratio
7.31
6.48
5.73
4.97
ROE
15.99
12.5
13.74
14.64
FCFF
-86.77
164.69
222.26
306.54
FCFF Yield
Net Debt
-1027.71
-1182.1
-1345.2
-1595.37
BVPS
272.95
308.26
348.68
401.43

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
403.21
384.78
4.79%
440.83
378.07
16.60%
424.21
339.60
24.91%
420.01
337.29
24.52%
Expenses
297.07
280.98
5.73%
321.37
281.62
14.11%
309.67
249.38
24.18%
304.69
253.06
20.40%
EBITDA
106.14
103.79
2.26%
119.46
96.46
23.84%
114.54
90.22
26.96%
115.33
84.23
36.92%
EBIDTM
26.32%
26.98%
27.10%
25.51%
27.00%
26.57%
27.46%
24.97%
Other Income
41.69
16.92
146.39%
24.31
14.97
62.39%
21.80
16.57
31.56%
26.10
14.09
85.24%
Interest
2.95
3.16
-6.65%
2.17
3.13
-30.67%
3.33
3.47
-4.03%
3.34
2.22
50.45%
Depreciation
23.26
19.53
19.10%
21.03
16.08
30.78%
21.51
16.21
32.70%
20.85
15.99
30.39%
PBT
121.62
98.02
24.08%
120.58
92.23
30.74%
111.51
87.11
28.01%
117.23
80.11
46.34%
Tax
29.86
24.42
22.28%
31.01
24.10
28.67%
28.00
22.81
22.75%
30.53
18.76
62.74%
PAT
91.76
73.61
24.66%
89.56
68.13
31.45%
83.51
64.30
29.88%
86.70
61.35
41.32%
PATM
22.76%
19.13%
20.32%
18.02%
19.69%
18.93%
20.64%
18.19%
EPS
9.19
7.71
19.20%
9.06
7.12
27.25%
8.41
6.78
24.04%
8.63
6.48
33.18%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
1,688.26
1,669.83
1,375.80
1,115.23
923.06
786.47
687.24
610.83
520.42
455.01
412.26
Net Sales Growth
17.26%
21.37%
23.36%
20.82%
17.37%
14.44%
12.51%
17.37%
14.38%
10.37%
 
Cost Of Goods Sold
553.65
447.07
393.31
321.72
281.60
212.45
170.01
164.86
124.64
116.82
114.12
Gross Profit
1,134.61
1,222.77
982.49
793.51
641.47
574.02
517.23
445.97
395.78
338.19
298.14
GP Margin
67.21%
73.23%
71.41%
71.15%
69.49%
72.99%
75.26%
73.01%
76.05%
74.33%
72.32%
Total Expenditure
1,232.80
1,214.66
1,015.80
847.83
708.05
569.98
521.11
479.59
398.46
361.54
324.50
Power & Fuel Cost
-
53.56
44.29
38.59
29.84
25.27
25.62
24.74
19.04
16.78
15.22
% Of Sales
-
3.21%
3.22%
3.46%
3.23%
3.21%
3.73%
4.05%
3.66%
3.69%
3.69%
Employee Cost
-
301.53
245.91
202.75
163.62
141.76
138.76
116.61
99.13
87.26
74.77
% Of Sales
-
18.06%
17.87%
18.18%
17.73%
18.02%
20.19%
19.09%
19.05%
19.18%
18.14%
Manufacturing Exp.
-
288.05
234.53
208.57
172.94
138.87
129.76
121.66
112.98
96.95
85.38
% Of Sales
-
17.25%
17.05%
18.70%
18.74%
17.66%
18.88%
19.92%
21.71%
21.31%
20.71%
General & Admin Exp.
-
58.19
49.42
38.99
32.52
29.26
33.72
29.74
21.22
21.02
16.70
% Of Sales
-
3.48%
3.59%
3.50%
3.52%
3.72%
4.91%
4.87%
4.08%
4.62%
4.05%
Selling & Distn. Exp.
-
43.35
27.25
20.99
15.68
13.80
15.37
15.89
13.98
17.02
12.88
% Of Sales
-
2.60%
1.98%
1.88%
1.70%
1.75%
2.24%
2.60%
2.69%
3.74%
3.12%
Miscellaneous Exp.
-
22.91
21.08
16.23
11.86
8.57
7.87
6.10
7.48
5.70
12.88
% Of Sales
-
1.37%
1.53%
1.46%
1.28%
1.09%
1.15%
1.00%
1.44%
1.25%
1.31%
EBITDA
455.47
455.17
360.00
267.40
215.01
216.49
166.13
131.24
121.96
93.47
87.76
EBITDA Margin
26.98%
27.26%
26.17%
23.98%
23.29%
27.53%
24.17%
21.49%
23.43%
20.54%
21.29%
Other Income
113.90
89.13
58.75
36.19
37.90
18.41
18.46
18.48
14.38
13.53
8.27
Interest
11.79
14.32
13.56
10.86
6.16
10.64
20.48
13.75
11.58
8.67
9.95
Depreciation
86.65
82.64
63.44
57.17
53.95
47.52
40.53
37.29
29.24
23.73
21.03
PBT
470.94
447.33
341.74
235.56
192.80
176.74
123.58
98.68
95.51
74.60
65.04
Tax
119.40
113.96
86.01
58.21
48.74
44.18
29.85
34.68
26.16
20.06
17.57
Tax Rate
25.35%
25.48%
25.17%
24.71%
25.28%
25.00%
24.15%
35.14%
27.39%
26.89%
27.01%
PAT
351.53
338.56
258.26
179.28
146.51
135.87
93.74
64.00
69.35
54.54
47.47
PAT before Minority Interest
351.53
338.56
258.26
179.28
146.51
135.87
93.74
64.00
69.35
54.54
47.47
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
20.82%
20.28%
18.77%
16.08%
15.87%
17.28%
13.64%
10.48%
13.33%
11.99%
11.51%
PAT Growth
31.47%
31.09%
44.05%
22.37%
7.83%
44.94%
46.47%
-7.71%
27.15%
14.89%
 
EPS
34.70
33.42
25.49
17.70
14.46
13.41
9.25
6.32
6.85
5.38
4.69

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
2,765.66
1,470.05
1,241.63
1,087.48
965.57
434.82
381.37
338.30
271.54
228.63
Share Capital
50.66
47.99
47.97
47.95
47.94
44.12
44.12
44.11
44.11
22.06
Total Reserves
2,712.71
1,418.67
1,191.35
1,038.01
916.84
390.56
336.95
293.77
227.43
206.57
Non-Current Liabilities
56.30
37.38
42.28
62.68
86.76
139.23
118.99
103.95
71.56
49.48
Secured Loans
0.00
0.84
11.56
30.56
59.74
114.41
91.38
79.12
47.62
31.06
Unsecured Loans
0.00
0.00
5.94
7.56
3.54
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
9.43
6.26
4.60
3.98
3.27
3.80
3.13
2.10
3.33
2.57
Current Liabilities
457.81
424.59
351.17
226.68
215.10
225.49
181.24
122.58
113.85
109.25
Trade Payables
86.42
95.60
92.31
89.04
64.52
66.36
55.54
43.62
41.86
30.87
Other Current Liabilities
101.80
100.85
92.72
78.57
66.90
72.25
48.99
46.39
39.32
39.89
Short Term Borrowings
174.70
150.91
106.88
58.72
38.82
53.18
45.47
32.24
32.30
33.46
Short Term Provisions
94.88
77.23
59.25
0.35
44.86
33.71
31.24
0.33
0.38
5.03
Total Liabilities
3,279.77
1,932.02
1,635.08
1,376.84
1,267.43
799.54
681.60
564.83
456.95
387.36
Net Block
1,084.32
866.81
634.35
484.23
421.22
359.49
302.74
261.79
206.07
182.35
Gross Block
1,596.05
1,311.18
1,018.82
818.46
706.56
599.92
507.83
430.48
344.86
298.59
Accumulated Depreciation
511.73
444.38
384.47
334.23
285.34
240.42
205.09
168.69
138.79
116.24
Non Current Assets
1,275.13
1,017.05
770.52
593.40
519.62
449.54
352.28
309.62
252.03
216.76
Capital Work in Progress
101.07
75.71
78.16
43.40
21.21
24.71
19.42
18.25
20.00
13.72
Non Current Investment
20.51
27.57
7.64
9.77
9.40
12.92
10.79
10.28
3.92
4.42
Long Term Loans & Adv.
55.50
38.63
41.89
32.25
12.73
19.54
8.82
13.70
17.45
12.89
Other Non Current Assets
13.73
7.75
7.58
19.88
50.54
32.88
10.51
5.60
4.59
3.38
Current Assets
2,004.64
914.98
864.55
783.44
747.81
350.00
329.32
255.20
204.92
170.60
Current Investments
1,056.61
139.54
124.02
336.60
345.01
15.92
0.27
10.62
0.00
0.00
Inventories
285.57
221.03
208.65
168.36
126.48
112.09
83.79
72.99
61.95
46.00
Sundry Debtors
349.73
269.94
235.43
206.63
155.86
127.12
128.38
112.54
95.53
82.98
Cash & Bank
151.34
146.86
177.63
15.44
29.56
25.36
54.59
20.39
22.68
21.73
Other Current Assets
161.37
16.90
15.75
12.44
90.89
69.51
62.29
38.66
24.77
19.89
Short Term Loans & Adv.
148.04
120.71
103.06
43.98
68.88
56.20
40.83
16.65
10.29
10.97
Net Current Assets
1,546.83
490.39
513.38
556.76
532.71
124.51
148.08
132.63
91.07
61.35
Total Assets
3,279.77
1,932.03
1,635.07
1,376.84
1,267.43
799.54
681.60
564.82
456.95
387.36

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
240.42
266.08
191.05
123.47
118.73
128.30
106.48
74.96
56.07
63.20
PBT
452.52
344.27
237.49
195.24
180.05
125.72
98.68
95.51
74.60
65.04
Adjustment
34.63
36.77
60.89
39.08
44.48
50.59
44.23
39.93
23.28
26.00
Changes in Working Capital
-154.32
-40.66
-49.46
-63.39
-61.19
-12.07
-8.69
-37.35
-23.60
-13.95
Cash after chg. in Working capital
332.83
340.38
248.92
170.93
163.35
164.24
134.21
98.09
74.28
77.09
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-92.41
-74.30
-57.87
-47.46
-44.62
-35.93
-27.72
-23.14
-18.21
-13.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-1,194.28
-240.94
-179.24
-85.33
-435.58
-107.26
-100.74
-88.03
-55.67
-31.38
Net Fixed Assets
-303.94
-284.72
-233.08
-131.91
-100.55
-95.55
-43.89
-82.07
-51.29
-40.24
Net Investments
-906.66
-39.63
202.56
1.27
-323.40
-15.59
-24.01
-15.56
-0.64
0.00
Others
16.32
83.41
-148.72
45.31
-11.63
3.88
-32.84
9.60
-3.74
8.86
Cash from Financing Activity
950.51
-20.15
-12.51
-35.34
316.95
-20.51
-5.13
15.71
-0.28
-30.77
Net Cash Inflow / Outflow
-3.35
4.99
-0.70
2.80
0.10
0.54
0.62
2.64
0.11
1.06
Opening Cash & Equivalents
12.05
7.06
7.76
4.95
4.86
4.32
3.70
1.06
0.95
11.86
Closing Cash & Equivalent
8.70
12.05
7.06
7.76
4.95
4.86
4.32
3.70
1.06
12.91

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
272.72
152.82
129.17
113.24
100.62
49.26
43.19
38.30
30.78
25.91
ROA
12.99%
14.48%
11.90%
11.08%
13.15%
12.66%
10.27%
13.58%
12.92%
12.64%
ROE
16.01%
19.09%
15.42%
14.29%
19.42%
22.98%
17.80%
22.76%
21.81%
22.35%
ROCE
20.37%
23.63%
19.10%
17.42%
21.96%
24.43%
22.19%
25.39%
24.37%
25.59%
Fixed Asset Turnover
1.15
1.19
1.22
1.22
1.21
1.24
1.30
1.35
1.44
1.49
Receivable days
67.43
66.78
72.05
71.34
65.34
67.85
71.98
72.79
70.54
63.66
Inventory Days
55.13
56.78
61.45
58.03
55.09
52.02
46.84
47.20
42.65
45.25
Payable days
74.30
87.19
102.88
99.52
112.43
41.75
38.03
38.55
36.95
39.11
Cash Conversion Cycle
48.25
36.37
30.62
29.84
8.01
78.12
80.80
81.45
76.24
69.80
Total Debt/Equity
0.06
0.12
0.12
0.12
0.14
0.47
0.42
0.39
0.37
0.36
Interest Cover
32.59
26.38
22.87
32.68
17.92
7.04
8.18
9.25
9.61
7.54

News Update:


  • Poly Medicure gets nod to acquire PendraCare Group
    4th Sep 2025, 11:08 AM

    Post completion of acquisition, the company, through Risor Holding B. V. will own 90% of the Economic Rights in the PendraCare group

    Read More
  • Poly Medicure - Quarterly Results
    8th Aug 2025, 14:31 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.